ENTITY
Divi's Laboratories

Divi's Laboratories (DIVI IN)

90
Analysis
Health CareIndia
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
02 Jun 2024 17:32

Divi's Laboratories (DIVI IN): Custom Synthesis Business to Drive Future Growth

​Divi's Laboratories is in the process of entering into a long-term custom synthesis supply agreement with an MNC customer. The company is expected...

Logo
361 Views
Share
04 Jan 2025 08:43

Anthem Biosciences Pre-IPO: High Visibility Powered by Differentiated Capabilities

Anthem Biosciences, a Contract Research, Development, and Manufacturing Organization, has filed DRHP for an Indian IPO. The proposed IPO will be...

Logo
582 Views
Share
bearishSagility India
06 May 2025 02:31

Sagility India IPO Lockup - US$1.5bn Lockup Release; PE Promoter Will Have to Trim for Free-Float

Sagility India raised around US$250m in its India IPO in Nov 2024. Its six-month lockup on its pre-IPO investors will expire on 8th May 2025.

Logo
460 Views
Share
20 Apr 2025 00:30

APAC Healthcare Weekly (April 20)- Neuren, Chugai, Eisai, Telix, Biocon, Aurobindo Pharma

Neuren is a step closer to P3 trial in PMS. Chugai’s oral GLP-1 drug candidate shows promise in P3 trial. Eisai got Leqembi approval in EU. Biocon...

Logo
595 Views
Share
03 Apr 2025 09:51

Decoding Trump’s Reciprocal Tariffs: Limited Shock for India, Sector Rotation Ahead

​Trump's reciprocal tariff plan on Indian goods spares pharma and IT, impacting autos, textiles, chemicals, and solar exports. Investors may shift...

Logo
278 Views
Share
x